close
MENU
Hot Topic Hawke’s Bay
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Hawke’s Bay
Guest Opinion
4 mins to read
5

NZ medicinal cannabis sector doesn't deserve criticism

OPINION: Celebrate the new sector, says Helius Therapeutics CEO.

Helius CEO Carmen Doran.

Carmen Doran Sat, 09 Jul 2022

The latest Ministry of Health data on medicinal cannabis uptake paints a positive picture. This comes despite ongoing criticism on the availability of local products, price, and doctors’ willingness to prescribe.

Yes, challenges around access continue, but New Zealand’s newest industry is making

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Carmen Doran Sat, 09 Jul 2022
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Helius Therapeutics Carmen Doran Sativex Medicinal Cannabis Scheme Medsafe MCinfo Don Budge medicinal cannabis
Related News
General Business

Southland farmers dabbling in medicinal cannabis sign up for second year
Politics
8

Cannabis could be New Zealand’s next wine, minister says
General Business

New Zealand cannabis industry ripe for big pharma acquisitions

Related News
General Business

Southland farmers dabbling in medicinal cannabis sign up for second year
Politics
8

Cannabis could be New Zealand’s next wine, minister says
General Business

New Zealand cannabis industry ripe for big pharma acquisitions

NZ medicinal cannabis sector doesn't deserve criticism
Guest Opinion,
94742
true
Subscribe Login